Antiviral Therapy and Hepatitis B Virus-Related Hepatocellular Carcinoma Recurrence

被引：2
|
作者：
Hsu, Ching-Sheng [1 ]
机构：
[1] Buddhist Tzu Chi Gen Hosp, Dept Internal Med, Taipei Branch, Taipei, Taiwan
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2013年 / 309卷 / 08期
关键词：
ASSOCIATION;
D O I：
10.1001/jama.2013.568
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：765 / 765
页数：1
相关论文
共 50 条
  • [31] Impact of aldo-keto reductase family 1 member B10 on the risk of hepatitis C virus-related hepatocellular carcinoma
    Sato, Shunsuke
    Genda, Takuya
    Ichida, Takafumi
    Murata, Ayato
    Tsuzura, Hironori
    Narita, Yutaka
    Kanemitsu, Yoshio
    Ishikawa, Sachiko
    Kikuchi, Tetsu
    Mori, Masashi
    Hirano, Katsuharu
    Iijima, Katsuyori
    Wada, Ryo
    Nagahara, Akihito
    Watanabe, Sumio
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 (07) : 1315 - 1322
  • [32] Combined effects of p53 and MDM2 polymorphisms on susceptibility and surgical prognosis in hepatitis B virus-related hepatocellular carcinoma
    Yang, Yun
    Xia, Tian
    Li, Ning
    Zhang, Jin
    Yang, Yuan
    Cong, Wenming
    Deng, Qiang
    Lan, Ke
    Zhou, Weiping
    PROTEIN & CELL, 2013, 4 (01) : 71 - 81
  • [33] Interleukin-17A and interleukin-17F gene polymorphisms and hepatitis B virus-related hepatocellular carcinoma risk in a Chinese population
    Xi, Xue-E
    Liu, Yanqiong
    Lu, Yu
    Huang, Liying
    Qin, Xue
    Li, Shan
    MEDICAL ONCOLOGY, 2015, 32 (01) : 1 - 8
  • [34] Antiviral Therapy Reduces Mortality in Hepatocellular Carcinoma Patients with Low-Level Hepatitis B Viremia
    Wang, Xinhui
    Liu, Xiaoli
    Wang, Peng
    Yu, Lihua
    Yan, Fengna
    Yan, Huiwen
    Zhou, Dongdong
    Yang, Zhiyun
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2021, 8 : 1253 - 1267
  • [35] Hepatitis C virus-related vasculitis
    Boleto, Goncalo
    Vieira, Matheus
    Saadoun, David
    Cacoub, Patrice
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2021, 45 (05)
  • [36] Impact of antiviral therapy on risk prediction model for hepatocellular carcinoma development in patients with chronic hepatitis B
    Chon, Hye Yeon
    Lee, Jae Seung
    Lee, Hye Won
    Chun, Ho Soo
    Kim, Beom Kyung
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Kim, Seung Up
    HEPATOLOGY RESEARCH, 2021, 51 (04) : 406 - 416
  • [37] Serum concentrations of selected adipokines in virus-related liver cirrhosis and hepatocellular carcinoma
    Pazgan-Simon, Monika
    Zuwala-Jagiello, Jolanta
    Kukla, Michal
    Grzebyk, Ewa
    Simon, Krzysztof
    CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2020, 6 (03) : 235 - 242
  • [38] Diabetes mellitus affects long-term survival in hepatitis B virus-related hepatocellular carcinoma patients A propensity score-matched analysis
    Zhang, Haili
    Li, Hongyu
    Lan, Xiang
    Liu, Fei
    Li, Bo
    Wei, Yonggang
    MEDICINE, 2021, 100 (04)
  • [39] Quantitative methylation analysis reveals gender and age differences in p16INK4a hypermethylation in hepatitis B virus-related hepatocellular carcinoma
    Wang, Yongfeng
    Cheng, Jin
    Xu, Chunhui
    Liu, Shuang
    Jiang, Suzhen
    Xu, Qiang
    Chen, Xiangmei
    Zhuang, Hui
    Lu, Fengmin
    LIVER INTERNATIONAL, 2012, 32 (03) : 420 - 428
  • [40] IL-18 polymorphisms contribute to hepatitis B virus-related cirrhosis and hepatocellular carcinoma susceptibility in Chinese population: a case-control study
    Dai, Zhi-Jun
    Liu, Xing-Han
    Wang, Meng
    Guo, Yan
    Zhu, Wenge
    Li, Xiao
    Lin, Shuai
    Tian, Tian
    Liu, Kang
    Zheng, Yi
    Xu, Peng
    Jin, Tianbo
    Li, Xiaopeng
    ONCOTARGET, 2017, 8 (46) : 81350 - 81360
12345